MariMed Files Preliminary Non-Offering Prospectus And Applies For Dual Listing on Canadian Securities Exchange

1.3 min readPublished On: April 7th, 2022By

NORWOOD, Mass. – MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator focused on improving lives every day, today announced that it has filed a preliminary non-offering long form prospectus with the securities regulatory authorities in the Provinces of Ontario and British Columbia. No securities are being sold pursuant to the Prospectus and no proceeds are being raised.

The Company also announced that it has applied to list its common shares on the Canadian Securities Exchange. Listing and trading of the Common Shares will be subject to the Company fulfilling all the CSE’s listing requirements and the Company being receipted for a final prospectus with the securities regulatory authorities in the Provinces of Ontario and British Columbia.

“We are excited to announce this significant milestone of applying for a dual listing on the CSE,” said Robert Fireman, Chief Executive Officer of MariMed. “We believe the potential trading of our Common Shares on the CSE will increase liquidity for our shareholders, and provide access to a significant pool of prospective retail and institutional investors in addition to our current long-term investors we have on the OTCQX market.”

A copy of the Prospectus is available under the Company’s profile on SEDAR at www.sedar.com. There can be no guarantee that a receipt for the final prospectus will be obtained from the securities regulatory authorities in the Provinces of Ontario and British Columbia or that the CSE will accept the listing of the Common Shares.

(This information is primarily sourced from MariMed Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!